RNA

Atrium Therapeutics, Inc. Common Stock

$12.68 -2.46%

Recent alerts on RNA

All signals →

News Top Performing Industry ETFs In June: Software Leads Returns, Chipmakers Attract Most Inflows

News Avidity (RNA) Up 33% on Rare Muscle Disease Study Results

News A Glimpse Into The Expert Outlook On Avidity Biosciences Through 6 Analysts

News Atrium Therapeutics, Inc. reports Q1 results

News Novartis Offers High-Grade Debt to Fund $12 billion Avidity Deal

Insider trade Sale by LEVIN ARTHUR A

Insider trade Sale by Teresa Mccarthy

Insider trade Sale by Michael W. Flanagan

Insider trade Sale by Michael F Maclean

Insider trade Sale by Steven George Hughes

Insider trade Sale by Sarah Boyce

Short volume Short volume 50% of volume (4.1σ)

News $HAREHOLDER ALERT: The M&A Class Action Firm Continues to Investigate the Merger--TBHC, RNA, NEW, and TWO

News ClearBridge Small Cap Strategy adds Upwork, exits Alexander & Baldwin in Q4

Short volume Short volume 69% of volume (6.4σ)

News Mega-to-large cap healthcare stocks with the weakest earnings momentum

News Avid Bioservices nomme Rich McAvoy au poste de Directeur commercial

News Avid Bioservices Appoints Rich McAvoy as Chief Business Officer

News Novartis agrees to acquire Avidity Biosciences, an innovator in RNA therapeutics, strengthening its late-stage neuroscience pipeline

News RNA STOCK ALERT: HALPER SADEH LLC IS INVESTIGATING WHETHER THE SALE OF AVIDITY BIOSCIENCES, INC. IS FAIR TO SHAREHOLDERS

News Avidity Shareholders Win Big As Novartis Moves Fast On $12 Billion Deal

News Novartis Maintains Outlook Even As Generics Bite Into Profits

News Novartis Projects Faster Growth Through 2030 After Raising Drug Forecasts

Scanner Unusual volume (z=3.6)

Scanner Unusual volume (z=3.3)

Get push alerts for RNA

Add it to your watchlist in the app and receive every signal the moment it fires.

Download for iOS

Download for iOS